Groupama Asset Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$565K Buy
1,055
+3
+0.3% +$1.68K 0.01% 301
2026
Q1
$591K Sell
1,052
-214
-17% -$137K 0.01% 283
2025
Q4
$856K Sell
1,266
-101
-7% -$68.8K 0.01% 266
2025
Q3
$873K Buy
+1,367
New +$830K 0.01% 284
2024
Q4
– Sell
-1,011
Closed -$410K – 458
2024
Q3
$410K Buy
1,011
+5
+0.5% +$2.43K 0.01% 359
2024
Q2
$490K Buy
1,006
+804
+398% +$404K 0.01% 370
2024
Q1
$109K Hold
202
– – ﹤0.01% 448
2023
Q4
$112K Buy
+202
New +$94.8K ﹤0.01% 395

Other funds holding IDXX

Groupama Asset Management's IDXX Position: Q2 2026 in Review

Groupama Asset Management increased its Idexx Laboratories (IDXX) stake by 0.29% in Q2 2026, buying an estimated $1.68K and bringing the position to 1,055 shares worth $565K. The position accounts for 0.01% of the portfolio, ranked #301.

Groupama Asset Management first reported a position in IDXX in Q4 2023 and has held it in 8 quarters since. The position peaked at $873K in Q3 2025. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Groupama Asset Management held 1,055 shares of Idexx Laboratories worth $565K as of Q2 2026.
  • Groupama Asset Management bought 3 Idexx Laboratories shares in Q2 2026, an estimated $1.68K.
  • Idexx Laboratories made up 0.01% of Groupama Asset Management's portfolio in Q2 2026, its #301 holding.
  • Groupama Asset Management first reported a position in Idexx Laboratories in Q4 2023 and has held it in 8 quarters since.
  • Groupama Asset Management's Idexx Laboratories position peaked at $873K in Q3 2025.
  • 1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Groupama Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.